America's biotech companies have spent a staggering $42.5 billion developing treatments for Alzheimer's since 1995.
CMS's Devastating Blow to American Seniors
Comment
Show comments
Hide Comments
America's biotech companies have spent a staggering $42.5 billion developing treatments for Alzheimer's since 1995.
